Search Within

Anuja Kriplani

Formats
  1. Meeting Abstract (19)
  2. Journal Article (11)
  3. Review (1)
Groups
  1. Department of Medicine (31)
  2. Head and Neck Service (31)
  3. Solid Tumor Oncology Division (31)
  4. Epidemiology and Biostatistics (18)
  5. Surgery (17)
  6. Survivorship Research (17)

More Groups

People
  1. Eric Sherman (19)
  2. Lara Dunn (17)
  3. David Pfister (16)
  4. Alan Ho (15)
  5. Loren Michel (15)
  6. James Fetten (12)

More People

Years
  1. 2024 (11)
  2. 2023 (6)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Annals of Oncology (2)
  3. Cancer (2)
  4. International Journal of Radiation Oncology, Biology, Physics (2)
  5. CA - A Cancer Journal for Clinicians (1)
  6. Cancer Medicine (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (16)
  2. Elsevier Inc. (4)
  3. Wiley Blackwell (3)
  4. American Medical Association (2)
  5. Oxford University Press (2)
  6. Future Medicine (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety of opioid prescribing among older cancer survivors
    Journal Article

    Salz, T.; Mishra, A.; Gennarelli, R. L.; Lipitz-Snyderman, A.; Moryl, N.; Tringale, K. R.; Boudreau, D. M.; Kriplani, A.; Jinna, S.; Korenstein, D.
    Cancer (2022)

    Fulltext@MSK | Save
  • The 30 ROC trial: Precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer
    Meeting Abstract

    Lee, N. Y.; Sherman, E. J.; Schòˆder, H.; McBride, S. M.; Yu, Y.; Kang, J.; Tsai, C. J.; Gelblum, D. Y.; Boyle, J.; Singh, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of fibroblast growth factor receptor inhibitor-associated retinopathy
    Journal Article

    Francis, J. H.; Harding, J. J.; Schram, A. M.; Canestraro, J.; Haggag-Lindgren, D.; Heinemann, M.; Kriplani, A.; Jhaveri, K.; Voss, M. H.; Bajorin, D.; more...
    JAMA Ophthalmology (2021)

    Fulltext@MSK | Save
  • The Head and Neck Survivorship Tool (HN-STAR) Trial (WF-1805CD): A protocol for a cluster-randomized, hybrid effectiveness-implementation, pragmatic trial to improve the follow-up care of head and neck cancer survivors
    Journal Article

    Salz, T.; Ostroff, J. S.; Nightingale, C. L.; Atkinson, T. M.; Davidson, E. C.; Jinna, S. R.; Kriplani, A.; Lesser, G. J.; Lynch, K. A.; Mayer, D. K.; more...
    Contemporary Clinical Trials (2021)

    Fulltext@MSK | Save
  • Trends in chronic opioid therapy among survivors of head and neck cancer
    Journal Article

    Kriplani, A.; Lavery, J. A.; Mishra, A.; Korenstein, D.; Lipitz-Snyderman, A. N.; Boudreau, D. M.; Moryl, N.; Gillespie, E. F.; Salz, T.
    Head & Neck (2021)

    Fulltext@MSK | Save
  • A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Ho, A. L.; Eng, J.; Michel, L. S.; Fetten, J. V.; Warner, E.; Kriplani, A.; Zhi, W. I.; Ng, K. K.; Haque, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC)
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Morris, L.; Ostrovnaya, I.; Katabi, N.; Haque, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Changing chemotherapy (C) with concurrent radiation (RT) followed by surgery after sub-optimal FDG-PET response to induction chemotherapy improves outcomes in locally advanced (LA) esophageal adenocarcinoma (EA)
    Meeting Abstract

    Kriplani, A.; Janjigian, Y. Y.; Kelsen, D. P.; Rusch, V. W.; Bains, M. S.; Rizk, N. P.; Chou, J. F.; Capanu, M.; Wu, A. J. C.; Goodman, K. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • MGMT immunohistochemistry (IHC) and exclusion of pancreatic NET (PanNET) patients from treatment with temozolomide-based therapy
    Meeting Abstract

    Reidy, D. L.; Basturk, O.; Kriplani, A.; Abou-Alfa, G. K.; Jarnagin, W. R.; Allen, P. J.; Saltz, L.; Klimstra, D. S.; Zhang, L. Y.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save